Canopy Growth Corporation (WEED.TO)
CAD 2.0
(21.21%)
CAD 2.0
(21.21%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 493.29 Million CAD | -34.23% |
| 2022 | 749.99 Million CAD | -49.72% |
| 2021 | 1.49 Billion CAD | -5.18% |
| 2020 | 1.57 Billion CAD | 176.44% |
| 2019 | 569.06 Million CAD | -32.44% |
| 2018 | 842.25 Million CAD | 12168.89% |
| 2017 | 6.86 Million CAD | -20.53% |
| 2016 | 8.63 Million CAD | 149.03% |
| 2015 | 3.46 Million CAD | 123.17% |
| 2014 | 1.55 Million CAD | 4328.59% |
| 2013 | 35.09 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 558.48 Million CAD | 13.22% |
| 2023 Q3 | 587.91 Million CAD | -16.16% |
| 2023 Q4 | 493.29 Million CAD | -16.09% |
| 2023 FY | 493.29 Million CAD | -34.23% |
| 2023 Q1 | 867.54 Million CAD | 15.67% |
| 2023 Q2 | 701.25 Million CAD | -19.17% |
| 2022 Q1 | 1.26 Billion CAD | -15.22% |
| 2022 Q2 | 1.03 Billion CAD | -18.39% |
| 2022 Q3 | 750.11 Million CAD | -27.32% |
| 2022 FY | 749.99 Million CAD | -49.72% |
| 2022 Q4 | 749.99 Million CAD | -0.02% |
| 2021 Q3 | 1.59 Billion CAD | 5.35% |
| 2021 FY | 1.49 Billion CAD | -5.18% |
| 2021 Q4 | 1.49 Billion CAD | -6.71% |
| 2021 Q2 | 1.51 Billion CAD | -7.35% |
| 2021 Q1 | 1.63 Billion CAD | 4.14% |
| 2020 Q1 | 574.84 Million CAD | 1.02% |
| 2020 Q2 | 520.42 Million CAD | -9.47% |
| 2020 Q3 | 718.1 Million CAD | 37.98% |
| 2020 FY | 1.57 Billion CAD | 176.44% |
| 2020 Q4 | 1.57 Billion CAD | 119.07% |
| 2019 Q2 | 590.37 Million CAD | -25.03% |
| 2019 Q4 | 569.06 Million CAD | 6.15% |
| 2019 Q3 | 536.1 Million CAD | -9.19% |
| 2019 Q1 | 787.5 Million CAD | -6.5% |
| 2019 FY | 569.06 Million CAD | -32.44% |
| 2018 Q2 | 6.7 Million CAD | -98.91% |
| 2018 FY | 842.25 Million CAD | 12168.89% |
| 2018 Q4 | 842.25 Million CAD | 8.95% |
| 2018 Q3 | 773.04 Million CAD | 11426.0% |
| 2018 Q1 | 617.74 Million CAD | 8898.53% |
| 2017 FY | 6.86 Million CAD | -20.53% |
| 2017 Q4 | 6.86 Million CAD | -5.88% |
| 2017 Q3 | 7.29 Million CAD | -8.36% |
| 2017 Q2 | 7.95 Million CAD | -3.21% |
| 2017 Q1 | 8.22 Million CAD | -4.82% |
| 2016 Q3 | 6.09 Million CAD | -4.24% |
| 2016 FY | 8.63 Million CAD | 149.03% |
| 2016 Q2 | 6.36 Million CAD | 82.34% |
| 2016 Q4 | 8.63 Million CAD | 41.81% |
| 2016 Q1 | 3.48 Million CAD | 0.58% |
| 2015 Q3 | 3.61 Million CAD | 6.26% |
| 2015 Q4 | 3.46 Million CAD | -3.91% |
| 2015 FY | 3.46 Million CAD | 123.17% |
| 2015 Q1 | 1.63 Million CAD | -2.09% |
| 2015 Q2 | 3.39 Million CAD | 107.91% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | 1.66 Million CAD | 7.37% |
| 2014 Q3 | 1.55 Million CAD | 0.0% |
| 2014 Q1 | - CAD | -100.0% |
| 2014 FY | 1.55 Million CAD | 4328.59% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | 35.09 Thousand CAD | 0.0% |
| 2013 Q4 | 33.1 Thousand CAD | -5.68% |
| 2013 FY | 35.09 Thousand CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | -936.898% |
| Avicanna Inc. | 95.36 Thousand CAD | -517185.711% |
| Avant Brands Inc. | 1.74 Million CAD | -28233.946% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -311063.677% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | -60426.871% |
| Knight Therapeutics Inc. | 44.01 Million CAD | -1020.715% |
| MediPharm Labs Corp. | 69 Thousand CAD | -714818.841% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -624322.785% |
| Willow Biosciences Inc. | 594 Thousand CAD | -82946.128% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | -506.139% |